遇见数据集

Safety and efficacy of barzolvolimab in adults with prurigo nodularis: A Phase 1b Study

收藏
NIAID Data Ecosystem2026-05-10 收录
官方服务:

资源简介:

Supplemental materials for brief report:Safety and efficacy of barzolvolimab, an anti-KIT monoclonal antibody, in adults with moderate-to-severe prurigo nodularis: A randomized phase 1b intravenous single-dose study

创建时间:
2025-09-19
二维码
社区交流群
二维码
科研交流群
商业服务